Kiniksa Pharmaceuticals (KNSA) Technical (Analysis) Reports Kiniksa Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Kiniksa Pharmaceuticals (KNSA)
Technical Analysis Report for USA stock KNSA Kiniksa Pharmaceuticals. Dated: 23 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock KNSA Kiniksa Pharmaceuticals then click here. or read Experts views on Kiniksa Pharmaceuticals or Forecast & share price targets of Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals Opened at 43.30 and Closed at: 43.05, which is 0.02% of previous session's close. It moved within a range of 42.51 and 43.84
The session was a Bearish session with an average volume of 567600, which is -23.93% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 4 days back on short term averages
A Dead cross was found 3 days back on mid term averages
Support for tomorrow is 42.12 and resistance for tomorrow is 43.45
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 42.43, 41.8 resistance for tomorrow's hourly charts is 43.76, 44.46
10 Day SMA for Kiniksa Pharmaceuticals (KNSA) is 44.84 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Kiniksa Pharmaceuticals (KNSA) is 46.23 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Kiniksa Pharmaceuticals (KNSA) is 45.9 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 43.92 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Kiniksa Pharmaceuticals is 39.65 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Kiniksa Pharmaceuticals is at 46.23 and 200 DMA is at 39.65, while 50 DMA and 100 DMA are at 45.9 and 43.92 respectively
Kiniksa Pharmaceuticals (KNSA) moving average of 20 SMA is at 46.23 and 20 EMA is at 45.34
| Date | Closing Price | 20 SMA | 20 EMA |
| 23 Thu Apr | 43.05 | 46.23 | 45.34 |
| 22 Wed Apr | 43.04 | 46.37 | 45.58 |
| 21 Tue Apr | 42.45 | 46.47 | 45.85 |
| 20 Mon Apr | 42.46 | 46.64 | 46.21 |
| 17 Fri Apr | 44.90 | 46.83 | 46.6 |
| 16 Thu Apr | 45.32 | 46.86 | 46.78 |
Kiniksa Pharmaceuticals (KNSA) moving average of 50 SMA is at 45.9 and 50 EMA is at 45.29
| Date | Closing Price | 50 SMA | 50 EMA |
| 23 Thu Apr | 43.05 | 45.9 | 45.29 |
| 22 Wed Apr | 43.04 | 45.92 | 45.38 |
| 21 Tue Apr | 42.45 | 45.92 | 45.48 |
| 20 Mon Apr | 42.46 | 45.93 | 45.6 |
| 17 Fri Apr | 44.90 | 45.95 | 45.73 |
| 16 Thu Apr | 45.32 | 45.95 | 45.76 |
Kiniksa Pharmaceuticals (KNSA) moving average of 100 SMA is at 43.92 and 100 EMA is at 43.65
| Date | Closing Price | 100 SMA | 100 EMA |
| 23 Thu Apr | 43.05 | 43.92 | 43.65 |
| 22 Wed Apr | 43.04 | 43.92 | 43.66 |
| 21 Tue Apr | 42.45 | 43.91 | 43.67 |
| 20 Mon Apr | 42.46 | 43.9 | 43.69 |
| 17 Fri Apr | 44.90 | 43.89 | 43.71 |
| 16 Thu Apr | 45.32 | 43.86 | 43.69 |
Kiniksa Pharmaceuticals (KNSA) moving average of 200 SMA is at 39.65 and 200 EMA is at 39.75
| Date | Closing Price | 200 SMA | 200 EMA |
| 23 Thu Apr | 43.05 | 39.65 | 39.75 |
| 22 Wed Apr | 43.04 | 39.57 | 39.72 |
| 21 Tue Apr | 42.45 | 39.5 | 39.69 |
| 20 Mon Apr | 42.46 | 39.42 | 39.66 |
| 17 Fri Apr | 44.90 | 39.35 | 39.63 |
| 16 Thu Apr | 45.32 | 39.26 | 39.58 |
Novo Nordisk has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Novo Nordisk, about 13.85% more returns!
Cvs Health has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Cvs Health, about 18.76% more returns!
Brookdale Senior has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Brookdale Senior, about 7.31% more returns!
Xeris Pharmaceuticals has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Xeris Pharmaceuticals, about 14.79% more returns!
Voyager Therapeutics has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Voyager Therapeutics, about 5.55% more returns!
Therapeuticsmd Inc has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Therapeuticsmd Inc, about 6.17% more returns!
Trinity Biotech has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Trinity Biotech, about 16.17% more returns!
Uniqure N has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Uniqure N, about 20.41% more returns!
Oncolytics Biotech has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Oncolytics Biotech, about 29.08% more returns!
Intellia Therapeutics has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 27.83% more returns!
Merit Medical has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Merit Medical, about 6.96% more returns!
Kiniksa Pharmaceuticals has performed better than Microbot Medical in short term. Holding Kiniksa Pharmaceuticals could be a better choice for now!
Gossamer Bio has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Gossamer Bio, about 5.34% more returns!
Kiniksa Pharmaceuticals has performed better than Galectin Therapeutics in short term. Holding Kiniksa Pharmaceuticals could be a better choice for now!
Fulgent Genetics has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Fulgent Genetics, about 5.89% more returns!
Angiodynamics Inc has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Angiodynamics Inc, about 7.35% more returns!
Addus Homecare has performed better than Kiniksa Pharmaceuticals in short term. You could have earned much better returns by investing in Addus Homecare, about 4.68% more returns!
Kiniksa Pharmaceuticals Technical analysis of indicators
Price action analysis of Kiniksa Pharmaceuticals (KNSA) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Kiniksa Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Kiniksa Pharmaceuticals in short term and the sell signal is strong.
Kiniksa Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Kiniksa Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Kiniksa Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 44.41 and Kiniksa Pharmaceuticals KNSA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Kiniksa Pharmaceuticals KNSA stock. Volume based technical analysis of Kiniksa Pharmaceuticals KNSA stock is negative.
Kiniksa Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock KNSA Kiniksa Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And KNSA Experts View which covers a lot of information including buying and selling signals
KNSA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Kiniksa Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Kiniksa Pharmaceuticals (KNSA) Technical (Analysis) Reports Kiniksa Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


